Highlights Ulisse Biomed S.p.A.

Equities

Real-time Borsa Italiana Other stock markets 11:04:27 29/05/2024 BST			5-day change	1st Jan Change
1.16 ^EUR	-0.85%		0.00%	-29.91%

05-27	Ulisse Biomed, agreement with Elettrobiochimica for IVDR kit development	AN
05-20	Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Ulisse Biomed, agreement with Elettrobiochimica for IVDR kit development	05-27	AN
Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	05-20	CI
Ulysses Biomed reduces loss in 2023; NFP is positive	05-03	AN
Mib in the red; Stellantis gives up double digits	04-30	AN
Ulisse Biomed, subsidiary sign distribution agreement with Mediline	03-18	AN
Ulisse Biomed, subsidiary sign partnership agreement with Generon	03-04	AN
Ulysses Biomed subsidiary concludes project worth more than EUR1 million	02-20	AN
Banks weigh on Mib in the red	02-13	AN
Hyris Fulfils Its Integration into Ulisse Biomed to Give Birth to A New International Group	01-15	CI
Futures bearish; new US data expected.	01-03	AN
Good banks and oil, Mib opens the year higher	01-02	AN
Ulysses Biomed, board of directors and board of auditors resign	12-29	AN
Ulysses Biomed, subsidiary sign agreement for agricultural test development	12-28	AN
Ulisse Biomed approves reverse take-over and aucap; Lo Priore new chair	12-21	AN
Ulysses Biomed, binding agreement to purchase 100 percent of Hyris	12-05	AN
Hyris Ltd. agreed to acquire Ulisse Biomed S.p.A. (BIT : UBM) on December 5, 2023.	12-04	CI
Microbix Biosystems Inc. Announces Collaboration with Ulisse Biomed S.P.A	11-10	CI
Ulisse Biomed S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	30/09/23	CI
Ulisse Biomed worsens half-year loss; revenues drop	29/09/23	AN
Ulysses Biomed doubles loss in 2022; improves NFP	28/03/23	AN

No results for this search